Dr. Urban Emmenegger is a Medical Oncologist, who in 2008 was appointed as a Clinician Scientist at the Odette Cancer Centre (Division of Medical Oncology) and the Sunnybrook Research Institute (Biological Sciences). He is Assistant Professor in the Department of Medicine, and Associate Member of the Institute of Medical Science, both at the University of Toronto.

Dr. Emmenegger obtained his medical degree from the University of Bern/Switzerland in 1992. Following training in Internal Medicine and Medical Oncology, in 2001 he joined the laboratory of Dr. Robert S. Kerbel (Sunnybrook Research Institute) to undertake postdoctoral training in tumor biology, with special emphasis on tumor angiogenesis and metronomic chemotherapy. He also completed a fellowship in Medical Oncology at the University of Toronto in 2008.

Dr. Emmenegger is specialized in the systemic treatment of advanced prostate cancer. Aside from clinical trial activities, he is interested in characterizing relevant drug-drug interactions between novel prostate cancer medications and medications frequently used by the typically elderly prostate cancer patient with numerous co-morbidities. His laboratory team aims to improve metronomic chemotherapy by characterizing mechanisms of resistance, and by identifying predictive markers of response. Additional studies focus on how fibroblast growth factor 23 contributes to aggressive prostate cancer behaviour.